Market Cap

$252.3B

Volume

8.6M

Cash and Equivalents

$14.6B

EBITDA

$22.9B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$48.4B

Profit Margin

76.59%

52 Week High

$134.63

52 Week Low

$94.48

Dividend

3.25%

Price / Book Value

5.67

Price / Earnings

20.86

Price / Tangible Book Value

43.57

Enterprise Value

$275.9B

Enterprise Value / EBITDA

11.86

Operating Income

$18.9B

Return on Equity

28.33%

Return on Assets

10.53

Cash and Short Term Investments

$14.6B

Debt

$38.1B

Equity

$44.6B

Revenue

$63.2B

Unlevered FCF

$14.8B

Sector

Pharmaceuticals

Category

N/A